| Serial Number | 79358195 |
| Word Mark | BIOCONNECTION |
| Filing Date | Wednesday, April 26, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 26, 2024 |
| Registration Number | 7574608 |
| Registration Date | Tuesday, November 26, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 25, 2024 |
| Goods and Services | Business consultancy services relating to manufacturing of medicinal and pharmaceutical preparations; business management advice relating to manufacturing business; advertising services; business management |
| Goods and Services | Medicines and pharmaceutical preparations, namely, for treatment of cardiovascular disorders, for treating diabetes, for treating allergies, for treating hypertension, for treating asthma, for use in urology, for use in dermatology, for treating skin disorders, for peripheral nervous system, for use in chemotherapy, for the treatment of hyperlipidemia, for the central nervous system, for treatment of infectious diseases, for the treatment of viral diseases, for the treatment of autoimmune diseases, for the treatment of musculo-skeletal disorders, for the treatment of gastro-intestinal diseases, for the treatment of immune system related diseases and disorders, kidney diseases or disorders, and diabetes; dietary supplements for humans and animals |
| Pseudo Mark | BIO CONNECTION |
| Goods and Services | Chemical additives for use in manufacturing of pharmaceuticals; chemical additives for use in the manufacture of medicaments; chemicals used in industry and science; active chemical ingredients for use in the manufacture of pharmaceuticals for treating cardiovascular disorders, for treating diabetes, for treating allergies, for treating hypertension, for treating asthma, for use in urology, for use in dermatology, for treating skin disorders, for peripheral nervous system, for use in chemotherapy, for the treatment of hyperlipidemia, for the central nervous system, for treatment of infectious diseases, for the treatment of viral diseases, for the treatment of autoimmune diseases, for the treatment of musculo-skeletal disorders, for the treatment of gastro-intestinal diseases, for the treatment of immune system related diseases and disorders, kidney diseases or disorders, and diabete |
| Goods and Services | Product research and development; research and development in the pharmaceutical and biotechnology field; research and development of new products for others; development of pharmaceutical preparations and medicines; services of bio technical, chemical and pharmaceutical laboratories, including scientific and technological research relating to the production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations, as well as providing expert advice in the field of pharmaceutical and veterinary preparations; carrying out early evaluations in the field of new medicines as part of scientific research; development of pharmaceutical preparations, medicines and medicaments; evaluation of pharmaceutical products as part of scientific analysis and research; research and development in the pharmaceutical field; advice regarding the aforesaid research, development and analysis services as part of consultations about medicines; advice regarding scientific research and analysis relating to medicines; information with regard to scientific research in the field of biochemistry and biotechnology; scientific research, including in the medical sector |
| Goods and Services | Contract manufacturing services in the field of preparing medicines and pharmaceutical products; custom manufacturing of biopharmaceuticals; custom manufacturing of pharmaceutical products, namely, for treatment of cardiovascular disorders, for treating diabetes, for treating allergies, for treating hypertension, for treating asthma, for use in urology, for use in dermatology, for treating skin disorders, for peripheral nervous system, for use in chemotherapy, for the treatment of hyperlipidemia, for the central nervous system, for treatment of infectious diseases, for the treatment of viral diseases, for the treatment of autoimmune diseases, for the treatment of Musculo-skeletal disorders, for the treatment of gastro-intestinal diseases, for the treatment of immune system related diseases and disorders, kidney diseases or disorders, and diabetes; preparing medicines and pharmaceutical products being contract manufacturing services, also with the aid of biotechnology |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 23, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 23, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 23, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 23, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 23, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BioConnection B.V. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | NL |
| Party Name | BioConnection B.V. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | NL |
| Party Name | BioConnection B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | NL |
| Event Date | Event Description |
| Thursday, December 22, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, December 23, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 27, 2022 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, January 17, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, January 17, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, January 17, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, January 17, 2023 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Tuesday, January 17, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, January 17, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, May 12, 2023 | ASSIGNED TO EXAMINER |
| Thursday, May 18, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, May 19, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sunday, June 25, 2023 | REFUSAL PROCESSED BY MPU |
| Monday, June 26, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, July 14, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 14, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, July 15, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, July 22, 2023 | REFUSAL PROCESSED BY IB |
| Tuesday, January 30, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, January 30, 2024 | FINAL REFUSAL WRITTEN |
| Tuesday, January 30, 2024 | FINAL REFUSAL E-MAILED |
| Tuesday, January 30, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, May 13, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, May 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 14, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 23, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 5, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 25, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 25, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 23, 2024 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Sunday, November 3, 2024 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, November 26, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 26, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Thursday, December 18, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, December 19, 2025 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |